ACTINIUM PHARMACEUTICALS, INC. Total Accounts Payable
ACTINIUM PHARMACEUTICALS, INC. (ATNM) had Total Accounts Payable of $1.01 thousand as of 2012-03-31, per its 10-Q filed 2012-04-23.
Discontinued › Notes › Payables and Accruals
us-gaap:AccountsPayable · last filed 2012-04-23
- 2012-03-31: Accounts Payable (Deprecated 2009-01-31) $1.01K.
- 2011-12-31: Accounts Payable (Deprecated 2009-01-31) $6.00.
| Period end | Accounts Payable (Deprecated 2009-01-31) |
|---|---|
| 2012-03-31 | $1.01K 10-Q · filed 2012-04-23 |
| 2011-12-31 | $6.00 10-Q · filed 2012-04-23 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| FILANA THERAPEUTICS, INC. (FLNA) | United States | $0.038B | -1.05 |
| PMGC Holdings Inc. (ELAB) | United States | $0.037B | |
| Celularity Inc (CELU) | United States | $0.038B | -0.34 |
| CervoMed Inc. (CRVO) | United States | $0.038B | -1.39 |
| BriaCell Therapeutics Corp. (BCTX) | $0.037B | ||
| Edesa Biotech, Inc. (EDSA) | Canada | $0.039B | |
| Seres Therapeutics, Inc. (MCRB) | United States | $0.036B | -3.45 |
| MIRA PHARMACEUTICALS, INC. (MIRA) | United States | $0.036B | -4.30 |
| Karyopharm Therapeutics Inc. (KPTI) | United States | $0.039B | -0.98 |
| Incannex Healthcare Inc. (IXHL) | $0.040B | -22.32 |